Recent data using anti-tumor models has demonstrated that strong stimulation via OX40 and OX40-L [24], 4-1BB activation [25] or OX40 stimulation and lymphopenia [26] could enhance CD4 CTL activity in a manner dependent on Eomesodermin. The gene discussed is CD4; the disease is lymphopenia.